115 related articles for article (PubMed ID: 6161957)
1. Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen.
Gerber MA; Garfinkel E; Hirschman SZ; Thung SN; Panagiotatos T
J Immunol; 1981 Mar; 126(3):1085-9. PubMed ID: 6161957
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructural analysis of hepatitis B surface antigen production in vitro.
Aoki N; Thung SN; Gerber MA
Lab Invest; 1982 Nov; 47(5):465-70. PubMed ID: 6182389
[TBL] [Abstract][Full Text] [Related]
3. Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA.
Shouval D; Reid LM; Chakraborty PR; Ruiz-Opazo N; Morecki R; Gerber MA; Thung SN; Shafritz DA
Cancer Res; 1981 Apr; 41(4):1342-50. PubMed ID: 6260336
[TBL] [Abstract][Full Text] [Related]
4. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
5. Distribution of hepatitis B surface and core antigens in human liver cell carcinoma and surrounding nontumorous liver.
Hirohashi S; Shimosato Y; Ino Y; Kishi K
J Natl Cancer Inst; 1982 Sep; 69(3):565-8. PubMed ID: 6287080
[TBL] [Abstract][Full Text] [Related]
6. Human hepatocellular carcinoma and putative precancerous disorders: their enzyme histochemical study.
Uchida T; Miyata H; Shikata T
Arch Pathol Lab Med; 1981 Apr; 105(4):180-6. PubMed ID: 6111303
[TBL] [Abstract][Full Text] [Related]
7. Distribution of five antigens in hepatocellular carcinoma.
Thung SN; Gerber MA; Sarno E; Popper H
Lab Invest; 1979 Aug; 41(2):101-5. PubMed ID: 88543
[TBL] [Abstract][Full Text] [Related]
8. Further studies on production and characterization of HBsAg derived from a human hepatoma cell line (PLC/PRF/5).
Barin F; Goudeau A; Brechot C; Romet-Lemonne J; Sureau C; Lesage G
Dev Biol Stand; 1983; 54():81-92. PubMed ID: 6317496
[TBL] [Abstract][Full Text] [Related]
9. Enzyme patterns in human hepatocellular carcinoma.
Gerber MA; Thung SN
Am J Pathol; 1980 Feb; 98(2):395-400. PubMed ID: 6243871
[TBL] [Abstract][Full Text] [Related]
10. Culturing of human hepatocellular carcinoma. A simple and reproducible method.
Laohathai K; Bhamarapravati N
Am J Pathol; 1985 Feb; 118(2):203-8. PubMed ID: 2578738
[TBL] [Abstract][Full Text] [Related]
11. Purification of HBsAg produced by the human hepatoma cell line PLC/PRE/5 by affinity chromatography using monoclonal antibodies and application for ELISA diagnostic.
Merten OW; Reiter S; Scheirer W; Katinger H
Dev Biol Stand; 1983; 55():121-7. PubMed ID: 6329855
[TBL] [Abstract][Full Text] [Related]
12. Patterns of hepatitis B surface antigen. Localization in cells of hepatocellular carcinoma.
Wu PC
Arch Pathol Lab Med; 1979 Apr; 103(4):165-8. PubMed ID: 85441
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of hepatitis B surface antigen expression in human hepatocellular carcinoma cell lines by HD-03, a polyherbal formulation.
Yeh SF; Gupta M; Sarma DN; Mitra SK
Phytother Res; 2003 Jan; 17(1):89-91. PubMed ID: 12557256
[TBL] [Abstract][Full Text] [Related]
14. A serum-free growth of a human hepatoma cell line as a tool for hepatocarcinogenesis and virus gene expression.
Bagnarelli P; Brugia M; Clementi M
Dev Biol Stand; 1985; 60():45-53. PubMed ID: 2995177
[TBL] [Abstract][Full Text] [Related]
15. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray.
Wang Y; Wu MC; Sham JS; Tai LS; Fang Y; Wu WQ; Xie D; Guan XY
J Pathol; 2002 Aug; 197(5):610-6. PubMed ID: 12210080
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
[TBL] [Abstract][Full Text] [Related]
17. Interferon-omega suppresses hepatitis B surface antigen production in human hepatoma cell line.
Hajnická V; Fuchsberger N; Liptáková H; Stancek D; Kontsek P
Acta Virol; 1996 Sep; 40(4):221-2. PubMed ID: 9014013
[TBL] [Abstract][Full Text] [Related]
18. The effect of glucocorticoid hormones on release of HBsAg from PLC/PRF/5 (Alexander) hepatoma cells.
Marshall J; Coulepis A; Pringle R; Dimitrakakis M; Gust ID
Acta Virol; 1983 Sep; 27(5):429-33. PubMed ID: 6139947
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
[TBL] [Abstract][Full Text] [Related]
20. Primary hepatocellular carcinoma with hepatitis B virus infection in a 16-year-old noncirrhotic patient.
Gasser RW; Judmaier G; Zur Nedden D; Aufschnaiter M; Hofstaedter F
Am J Gastroenterol; 1983 May; 78(5):305-8. PubMed ID: 6189392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
